Integrating and Navigating Strategies for Treating Chronic Pain, Mental Health, and Opioid Use Disorder

SCAN THIS QR Code

Dr. Wesley Sassaman, DNP, MSN-NE, MPH, MBA, FNP-C, CARN-AP

Living with chronic pain is challenging, but when it’s combined with anxiety, depression, and the struggles of opioid use disorder (OUD), it can feel like too much to bear. These conditions don’t just coexist—they influence and amplify each other, creating a cycle that’s incredibly hard to escape. But there is hope.

Understanding how these issues connect is a powerful first step toward breaking the cycle. By exploring integrated, personalized treatment options, you can take meaningful strides toward improving your quality of life. This guide will offer practical strategies that focus not just on symptom relief but on a holistic approach to nurturing both your physical and emotional well-being. Whether you’re considering alternatives to opioids, behavioral therapies, or new treatment paths, the information here is designed to help you regain a sense of control—one step at a time.

The most effective way to address chronic pain, paired with anxiety, depression, and OUD, is through a comprehensive, multimodal approach. This method combines both medical treatments and non-pharmacological therapies to provide well-rounded care.

When we talk about non-pharmacological therapies, options include behavioral health counseling, physical therapy, and even something as simple yet impactful as a daily walking routine. These strategies, guided by a biopsychosocial approach, aim to untangle the complex relationship between these conditions. They look beyond just managing symptoms, focusing on the deeper psychological and social factors that contribute to pain and emotional distress.

Parents often pour their energy into caring for others, but it's essential to also prioritize your own health. By addressing these challenges with a thoughtful, integrated plan, you can begin to reclaim a fulfilling, balanced life—for yourself and your family. With the right tools and support, brighter days are possible. So, take a deep breath, and let's dive into exploring your options for managing chronic pain accompanied by anxiety, depression, and OUD. Remember, you are not alone in this journey. There is hope and help available to improve your overall well-being. Together, we can find a path towards healing and living life to the fullest once again.

 Understanding More About Each of These Conditions Individually

Chronic Pain:

Chronic pain is defined as any type of persistent pain that lasts longer than three months. It can be caused by various factors such as injury, illness, nerve damage, or an underlying medical condition. Chronic pain affects millions of people around the world and can significantly impact daily activities, relationships, and overall quality of life. It is often accompanied by feelings of frustration, hopelessness, and isolation.

Anxiety:

Anxiety is a mental health disorder that can cause excessive worry, fear, and nervousness. People with chronic pain are more likely to experience anxiety due to the unpredictable nature of pain and its effect on daily functioning. Anxiety can also manifest in physical symptoms such as muscle tension, restlessness, and fatigue.

 

Depression:

Depression is a mood disorder that can cause persistent feelings of sadness, hopelessness, and loss of interest in activities once enjoyed. When living with chronic pain, individuals may feel overwhelmed by their condition's physical limitations and struggle with negative thoughts and emotions. Depression can also lead to changes in appetite, sleep patterns, and energy levels.

Opioid Use Disorder (OUD):

Opioids are powerful pain relievers that can be highly addictive. When used for long periods or in high doses, they can contribute to the development of OUD. This disorder is characterized by a strong craving for opioids, difficulty controlling use, and withdrawal symptoms when use is stopped. Individuals with chronic pain may turn to opioids as a means of managing their pain, leading to the potential for developing OUD.

It's essential to recognize that having any one of these conditions does not necessarily cause another. Still, there is a clear link between them due to their shared impact on the mind and body. The good news is that this also means that treating one condition can positively influence the others. By taking a comprehensive approach to managing chronic pain, anxiety, depression, and OUD, individuals can experience improved overall well-being (Jiménez-Fernández et al.,2022).

Some of the key elements of a multimodal treatment plan for these conditions may include medication management, behavioral therapies such as cognitive-behavioral therapy (CBT), physical therapy or exercise programs, mindfulness techniques, and support groups. It's crucial to work closely with a healthcare team to develop an individualized plan that addresses each person's unique needs and goals (Scott et al., 2023).

Remember, there is no one-size-fits-all solution when it comes to managing chronic pain with accompanying mental health conditions. It may take time and patience to find the right combination of treatments that work best for you, but don't give up hope. With a holistic approach and a supportive team by your side, it is possible to regain control over your life and find relief from the challenges of living with these complex conditions. You deserve to live a fulfilling and enjoyable life, free from the burden of chronic pain, anxiety, depression, and OUD. So keep pushing forward on this journey towards better physical and emotional well-being. You are not alone, and brighter days are ahead.

How the Biopsychosocial Model Can Make a Difference for Families

When you or a loved one is faced with conditions like depression, persistent pain, or even challenges related to opioid use, figuring out the best course of action can feel overwhelming. After all, these problems rarely have a single, clear cause. That’s where the biopsychosocial model comes in—a big, fancy-sounding term that just describes a way of looking at health that focuses on the whole person.

It’s not just about biology or brain chemistry, but about how psychological factors (like stress or coping skills) and social influences (like family, finances, and community) all come together to affect us.

This model brings hope to families because it’s not a one-size-fits-all approach. Instead, it looks at the full picture to offer more meaningful, personalized care. Whether someone is dealing with overwhelming sadness, constant pain, or struggles with addiction, the biopsychosocial model shows how recognizing the connections between these three arenas—biological, psychological, and social—can lead to better healing and support for everyone involved (Eucker, et al., 2022). Read on to discover how this approach works and how it can transform care for the ones you love.

A Holistic Understanding and Treatment Plan

Imagine you’re trying to solve a puzzle, and some of the pieces are missing. That’s often how treatment can feel when it focuses on just one angle, like medications or therapy, in isolation. Thankfully, the biopsychosocial model invites healthcare providers to take a step back and consider all the angles.

• Looking at the Whole Picture

  
  

  The real magic of this model lies in how it connects the dots. For a person living with chronic pain, for example, health professionals dig deeper into not just “What’s going wrong in the body?” but also “How is this pain impacting their emotional health?” or “Are they feeling unsupported by their family or workplace?” This interconnected view results in a clearer, fuller understanding of what their life is truly like. Studies back this up, showing that care guided by a biopsychosocial lens leads to improved outcomes (Abed et al., 2024; Silva, M. J. 2024).

• Integrating Various Therapies

  
  

  Because this approach blends insights from multiple areas, families can explore treatment combinations that work best for their unique needs. Take cognitive behavioral therapy (CBT) and mindfulness, for instance. These tools have been proven to ease both emotional distress and physical pain—a win-win for people navigating conditions like depression or fibromyalgia (Bradshaw et al., 2024).

When treatment focuses on both the mind and body in this way, it helps build healthier routines, more positive thinking patterns, and even stronger family connections.

Improving the Expertise of Care

It’s one thing for a health professional to believe in whole-person treatment; it’s another for them to be equipped to practice it well. The truth is, outdated thinking and rigid approaches have sometimes limited doctors and therapists from exploring biopsychosocial strategies. But positive changes are happening, and this evolution means better care for your family.

• Better Training for Providers

  
  

  Healthcare providers who go through biopsychosocial-focused training experience measurable improvements in how they treat and understand pain. This translates into treatments that follow evidence-based guidelines and can even help reduce an over-reliance on opioids (Munneke et al., 2024). In your family’s case, it could mean a care plan that offers safer and more effective relief for someone managing long-term pain.

• New Tools for Healing

  
  

  You may have heard of technologies like virtual reality (VR) making waves in entertainment, but they’re also breaking ground in medicine. VR tools are being used to bring biopsychosocial ideas to life, offering immersive pain management experiences tailored to a patient’s needs. Rather than just numbing pain, these tools help you or your loved one engage with care on a more personal level (Medina et al., 2024).

Addressing Social Factors That Impact Health

One of the key strengths of the biopsychosocial model is its focus on social factors—those parts of life that go beyond medical diagnoses to include the family, relationships, and community around the person. This can be a major game-changer, especially for anyone dealing with mental health issues or addiction.

• Why Social Support Matters

  
  

  Sometimes, emotional struggles or substance dependency aren’t just about individual choices—they’re tied to a web of external pressures. Maybe someone is isolated, stressed out at work, or dealing with family friction. The biopsychosocial model acknowledges these influences, which means treatment can also include changes in the social environment to make healing easier (Ongaro, 2024).

A child struggling with anxiety, for example, might benefit from therapies that involve the whole family. Or for someone recovering from opioid use disorder, addressing housing instability or unemployment could be just as critical as the medication they’re prescribed.

Challenges and the Path Forward

Like any approach, the biopsychosocial model isn’t without its challenges. For one, it demands that providers take the time and effort to fully integrate biological, psychological, and social factors into care—which can sometimes be tricky amidst busy clinic schedules or healthcare system barriers. Another difficulty lies in how underdeveloped the “social” piece often is, especially in psychiatric care.

But there’s reason to be optimistic. With more research and training, providers are finding ways to streamline this model into everyday practice. Families can advocate for this type of care too—by asking for multidisciplinary approaches or helping their loved ones build supportive social networks. Each small step can lead to big improvements over time.

Why Your Family Deserves This

Your family's challenges are unique, and so are your strengths. The biopsychosocial model celebrates that uniqueness by offering a framework that doesn’t just focus on symptoms but looks at the whole picture. Whether you’re caring for a teen wrestling with anxiety, helping a partner with chronic pain, or navigating recovery from opioid use disorder, this kind of holistic care aims to work as hard as you do for your family.

Because healing happens best when it honors the complexity of life—and that’s exactly what the biopsychosocial model is all about.

Chronic Pain, Mental Health, and Opioids Use Disorder: A Parent’s Guide to Understanding the Connection

Chronic pain isn’t just a physical ache—it’s much more than that. Imagine living with pain in your back, joints, or other areas for months or years. Over time, the burden of unrelenting pain doesn’t stay confined to the body. It begins to affect emotions, thoughts, and behaviors in complex ways. Many individuals with chronic pain eventually experience anxiety, depression, or both. For parents, understanding these connections through the lens of brain science can help you support your loved ones and advocate for better care.

The Pain-Mood Connection

Your body and brain work as a tightly interconnected system. When someone lives with chronic pain, their brain processes those signals differently than it processes short-term pain, like a stubbed toe or a headache. Persistent pain signals activate areas like the thalamus and prefrontal cortex (PFC), which aren’t just responsible for processing where the pain is but also play crucial roles in emotion, memory, and decision-making.

Research from Chen et al. (2024) showed how brain pathways connecting the insula, amygdala, and thalamus are impacted by chronic pain, leading to changes in how emotions like sadness and fear are processed. These disruptions play a significant role in comorbid depression-like behaviors. Similarly, Braden et al. (2024) examined the role of endogenous opioid activity in the dorsal raphe nucleus and highlighted how pain modulation and motivation are linked to natural chemical imbalances in the brain.

Sheng, et al (2017) found an amplified activation of certain brain circuits in those with chronic pain. This not only intensifies the sensation of pain but also increases emotional vulnerability, making individuals more likely to experience anxiety or depression.

Additionally, Cui et al. (2024) explored the neuronal and molecular mechanisms in the paraventricular thalamus, uncovering how this region contributes to both chronic pain and depression, pinpointing biochemical triggers that exacerbate comorbidities.

The Opioid Dilemma

Opioids are frequently prescribed to manage chronic pain, but they come with significant risks. These drugs target the brain's reward system, which relies heavily on dopamine to regulate feelings of pleasure and motivation. Over time, opioid use can lead to dependency or addiction, known as opioid use disorder (OUD).

Thompson et al. (2024) linked chronic pain to hypoactivity in mesolimbic dopamine neurons, impairing reward responses and altering behavior rooted in motivation and learning. These changes make breaking the cycle of opioid dependency incredibly challenging.

Further, Braden et al. (2024) revealed how disruptions in endogenous opioid peptides, naturally produced by the brain, become exacerbated with chronic opioid use. This creates a reinforcing loop of physical and emotional distress, deepening an individual’s dependence on medication.

How Chronic Pain Changes the Brain

Chronic pain is not just about what hurts in the moment; it fundamentally reshapes the structure and function of the brain. Key findings and areas of change include the following:

1. Prefrontal Cortex (PFC): This brain area helps regulate decision-making, emotional control, and planning. Chronic pain reduces its functionality, impairing emotional resilience, as emphasized by Kummer and Sheets (2024).

2. Thalamo-Subcortical Pathways: Deng et al. (2024) discovered how these circuits, responsible for relaying pain signals, are disrupted in cases of chronic pain. This disruption heightens pain feelings and fosters depression-like states.

3. White Matter Dysfunction: Ito et al. (2024) studied corticothalamic communication and white-matter health, highlighting dysfunctions that lead to poor pain modulation and a heightened risk of mood disorders.

4. Insula and Amygdala: Chen et al. (2024) found these regions are critical in bridging physical sensations of pain to emotional experiences like anxiety. Dysregulation here makes pain feel overwhelming and emotionally distressing.

5. Neuroplasticity: Kiritoshi et al. (2024) highlighted how prolonged pain alters neuronal connections, creating feedback loops where negative emotions reinforce pain.

6. Global Brain Impact: Efforts from the ENIGMA-Chronic Pain initiative, summarized by Quidé et al. (2024), are mapping chronic pain’s brain-wide effects. Findings show pain impacts areas associated with memory, executive function, and sensory processing.

Relatable Analogy

Picture the brain as an orchestra performing a symphony. For individuals without chronic pain, all instruments are in harmony, creating a balanced emotional and physical life. Chronic pain disrupts the violins, causing them to play too loudly, drowning out other sections. Then opioids mute those violins temporarily, but they don’t fix the underlying issue. Over time, this unresolved imbalance grows, eventually affecting the whole orchestra and the overall "music" of one's life.

Promising Research and Hope

The complexity of chronic pain, anxiety, and depression is daunting, but research offers hope. For instance, studies by Thompson et al. (2024) and Cui et al. (2024) are unraveling pathways that could lead to effective treatments targeting both pain and mood disorders.

Advanced imaging techniques, such as those highlighted by Zorina-Lichtenwalter et al. (2024) and the ENIGMA initiative (Quidé et al., 2024), are helping researchers understand how different brain regions interact under chronic pain conditions. Their work is paving the way for innovative therapies, including neurofeedback training and tailored cognitive-behavioral programs.

Furthermore, non-opioid pain treatments like nerve stimulation and selective medications are being explored. These methods hold promise for helping individuals manage pain without the risks associated with opioids.

Cannabidiol (CBD), a non-psychoactive compound from Cannabis sativa, is gaining recognition as a promising alternative to traditional therapies, such as opioids, in managing pain. Its strong analgesic properties, primarily linked to the activation of TRPV-1, 5HT-1A, and CB1 receptors, have shown significant potential for treating chronic pain conditions like osteoarthritis and neuropathic pain (Cásedas et al., 2024; Secondulfo et al., 2024). Compared to opioids, CBD provides similar pain relief with fewer risks, such as addiction or overdose (Jeddi et al., 2023). However, its low bioavailability remains a major challenge, prompting research into cyclodextrins (CDs) to improve its solubility and therapeutic effectiveness (Ribeiro et al., 2024). Further advancing its clinical application, a pragmatic trial is currently evaluating CBD’s safety and efficacy in managing chronic pain among U.S. veterans, a group facing a high prevalence of chronic pain and a critical need for improved treatment options (Bergmans et al., 2024). As research unfolds, CBD continues to highlight its potential in revolutionizing pain management while addressing the limitations of current therapies.

Action Steps for Parents

If you’re supporting a family member dealing with chronic pain, here are ways to help:

• Educate Yourself: Understanding chronic pain and its mental health connections allows you to make informed decisions and advocate effectively.

• Seek Multimodal Treatment: Encourage care plans that address physical and emotional health, integrating therapy, medication, and lifestyle adjustments.

• Promote Healthy Habits: Mindfulness, exercise, and sleep improvements can ease pain and support emotional resilience.

• Practice Open Communication: Establish a safe space for your loved ones to share their experiences, emotions, and needs.

Understanding Leads to Empowerment

Chronic pain, anxiety, depression, and opioid use disorder are deeply intertwined. Groundbreaking research from Braden et al. (2024), Chen et al. (2024), and Zorina-Lichtenwalter et al. (2024) stresses the importance of viewing these conditions through an interconnected lens. By drawing on the latest science, parents can provide compassionate, informed support and empower their loved ones toward healing.

Case Study Janet

Case Study: For Janet a 56-year-old women had recently been discharged and referred from her pain management clinic as a patient suffering from chronic pain grossly associated with degenerative disk disease, with a long history of mixed anxiety and depression with no manic behaviors or psychotic features reported. The referring provider notes that the patient has been over taking her oxycodone and is newly diagnosed with opioid use disorder, since she has been mixing her prescribed pain medication with street-based fentanyl. 

Plan: Pt is seeking to taper off her opioid use, while going through behavioral health counseling to address her anxiety and depression, along with a course of physical therapy.

Outcomes: Janet’s recovery exemplified the effectiveness of a biopsychosocial treatment model. After successfully transitioning from oxycodone to Suboxone, she reached a stabilizing daily dose of 16 mg. Her stabilization on Suboxone allowed her to manage cravings and pain effectively. Two months later, Janet elected to begin a gradual tapering off Suboxone, which she completed successfully. Notably, her pain, initially reported as 8 on a 0-10 scale before induction, decreased to less than 3 by the conclusion of her treatments, marking significant improvement in her physical health and quality of life.

Alongside her medical treatment, Janet benefited greatly from cognitive-behavioral therapy (CBT) to address her anxiety and depression. During her care, she was also prescribed Lexapro, starting at 10 mg and eventually increasing to 20 mg. This combination of pharmacological and therapeutic support resulted in remarkable progress—Janet reported zero scores for anxiety and depression, reflecting profound emotional recovery. Her participation in group therapy and relaxation techniques further bolstered her resilience and coping abilities. By the end of her recovery program, Janet expressed a desire to continue Lexapro under the guidance of her primary care physician, maintaining the mental health improvements achieved during her treatment.

Throughout her physical therapy sessions, Janet restored her mobility and strength using a structured approach that began with somatic quieting exercises and progressed to flexibility and strength training. These interventions, along with her reduction in pain, allowed her to resume daily activities with confidence and ease. By addressing anticipated challenges and providing continuous encouragement, Janet’s care team facilitated a holistic recovery. Her transition from dependence on opioids to long-term stability and emotional well-being demonstrates the success of a patient-centered, integrative approach to healing

Chronic Pain, Anxiety, Depression, and Opioid Use Disorder: Innovative Treatments, Advanced Pharmacology, and Integrated Care Solutions

Formulating a therapeutic approach for a patient with opioid use disorder (OUD) while also experiencing anxiety, depression, and chronic pain, requires a multifaceted strategy. This approach should address the patient's pain management needs, mental health conditions, and the risk of opioid misuse. The integration of pharmacological and non-pharmacological interventions is crucial to ensure effective treatment and minimize the risk of relapse or worsening of symptoms.

Pharmacological Interventions

• Methadone and Buprenorphine: Methadone has been shown to be effective in managing both pain and OUD symptoms, particularly in patients with complex conditions such as cancer and OUD. It can be considered as a potential treatment option for managing chronic pain and reducing opioid misuse in this patient population (Carli et al., 2023). Buprenorphine, another medication for OUD, can also be effective, especially when combined with naloxone to reduce the risk of misuse (Rudolph et al., 2021).

• Extended-Release Naltrexone: This medication has been found to reduce the risk of relapse in certain populations, although its effectiveness can vary based on individual factors such as housing status and adherence (Rudolph et al., 2021). It may be considered as part of a comprehensive treatment plan, particularly if the patient is at risk of opioid misuse.

• Kappa Opioid Receptor:  Khan et al. (2022) reviewed the kappa opioid receptor (KOR) and its ligands, showcasing their potential as therapeutic targets for managing pain, anxiety, depression, and drug abuse. The study highlighted that KOR agonists and antagonists play differing roles, with agonists mediating pain relief and intoxicating effects, while antagonists showing promise in reducing depressive and addictive behaviors. Their findings suggested that selectively targeting KOR pathways could lead to novel drugs with fewer side effects than traditional opioid therapies. The review identified this receptor as a key area for innovation, providing a foundation for developing safer, more specialized treatments in pain and mental health care.

Addressing Mental Health

• Screening and Treatment of Anxiety and Depression: Anxiety and depression significantly impact pain management outcomes and can exacerbate OUD. Screening for these conditions and providing appropriate treatment, such as cognitive-behavioral therapy or pharmacotherapy, is essential (Oliveira et al., 2019). Addressing these mental health issues can improve the patient's overall treatment outcomes and quality of life.

• Multidisciplinary Pain Management: A multidisciplinary approach that includes physical therapy, psychological support, and alternative therapies can be beneficial. This approach addresses the physical and psychological aspects of chronic pain and can help reduce reliance on opioids (Oliveira et al., 2019).

• Arts-Based Interventions: Integrative strategies, such as arts-based interventions, have been explored as complementary therapies for managing pain and substance use disorders. These interventions can provide emotional support and improve mental well-being, which may help in reducing opioid use (Leis & Morrison, 2021).

Harm Reduction and Community Support

• Harm Reduction Strategies: Implementing harm reduction strategies, such as supervised tapering and the use of naloxone for overdose prevention, can help manage the risks associated with opioid use (Deschamps et al., 2019). These strategies should be part of a broader community support system that includes continuous engagement with healthcare providers (Griffin, 2020).

• Community-Based Approaches: Engaging community stakeholders and applying systems engineering principles can enhance the effectiveness of OUD treatment and recovery efforts. This approach ensures that patients receive comprehensive care and support throughout their treatment journey (Griffin, 2020).

While the primary focus is on managing the patient's OUD and associated conditions, it is important to consider the potential challenges and limitations of opioid-based treatments. The development of biased opioid ligands, which aim to provide effective pain relief with reduced side effects, represents a promising area of research. These ligands target specific pathways to minimize the risk of addiction and other adverse effects, offering hope for safer pain management options in the future (Faouzi et al., 2020).

Conclusion

Living with chronic pain, mental health challenges, and opioid use disorder can feel overwhelming, but the key takeaway from this guide is that recovery is possible when approached holistically. The biopsychosocial model offers a pathway to address the physical, emotional, and social factors that intertwine these conditions. By integrating medical care, psychological support, and social connection, individuals can untangle the cycle of pain, anxiety, depression, and substance use.

We’ve explored how treatments like cognitive-behavioral therapy, tailored medications, and physical therapy can work together to provide relief and foster resilience. Stories of success, like Janet’s, prove that this approach not only reduces suffering but also restores functionality and emotional stability. The promise of advanced therapies and community-based interventions adds to the hope that brighter days are within reach for anyone facing these challenges.

If you or someone you love is navigating a similar situation, take heart in the fact that you are not alone. It may take time and patience, but with the right support and a comprehensive treatment plan, meaningful progress is achievable. Reach out, explore your options, and take the first step toward a life of improved well-being and renewed possibility. Healing can start today—one step at a time.

 References

1.        Abed, R., Hunt, A., & St John‐Smith, P. (2024). Evolutionary theory can advance and revitalise the biopsychosocial model. British Journal of Psychiatry, 1–3. Cambridge University Press.

2.        Bergmans, R. S., Wegryn‐Jones, R., Klida, C., Kurtz, V., Thomas, L., Williams, D. A., Clauw, D. J., Kidwell, K. M., Bohnert, A. M., & Boehnke, K. F. (2024). Protocol for a pragmatic trial of cannabidiol (CBD) to improve chronic pain symptoms among United States veterans. BMC Complementary Medicine and Therapies, 24(1). BioMed Central.

3.        Bradshaw, A., Bresnahan, R., Evans, E., Herron, K., & Hapangama, D. K. (2024). Biopsychosocial approaches for the management of female chronic pelvic pain: A systematic review. BJOG: An International Journal of Obstetrics. University of Liverpool.

4.        Braden, K., De Gregorio, D., Evans-Strong, A., & Castro, D. C. (2024). Endogenous opioid peptide in dorsal raphe nucleus modulates pain and motivation. The Journal of Pain.

5.        Carli, M., Fini, E., De Luca, G., Scarselli, M., Lamanna, F., Vico, T., & Bocci, G. (2023). Methadone dose escalation in patients with opioid use disorder and cancer as a strategy for controlling cancer-related pain: A case series. Palliative & Supportive Care, 1-4. University of Pisa. 

6.        Cásedas, G., de Yarza-Sancho, M., & López, V. (2024). Cannabidiol (CBD): A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals, 17(11), Article p. Multidisciplinary Digital Publishing Institute.

7.        Chen, J., Gao, Y., Bao, S. T., Wang, Y. D., Jia, T., Yin, C., Xiao, C., & Zhou, C. (2024). Insula-amygdala and insula-thalamus pathways are involved in comorbid chronic pain and depression-like behavior in mice. The Journal of Neuroscience.

8.        Cui, M., Ji, R., Song, L., Wang, X., Han, Y., Zhai, X., Ai, L., Zhang, W., Xie, A., Wu, Z., Song, W., Yang, J. X., Hu, A., Liu, H., Cao, J. L., & Zhang, H. (2024). Neuronal and molecular mechanisms underlying chronic pain and depression comorbidity in the paraventricular thalamus. The Journal of Neuroscience.

9.        Deng, J., Liu, C., Wei, J. Y., Fan, H. T., & Xu, T. (2024). Distinct thalamo‐subcortical circuits underlie painful behavior and depression‐like behavior following nerve injury. Advanced Science. Wiley.

10.  Deschamps, J., Gilbertson, J., Straube, S., Dong, K., MacMaster, F. P., Korownyk, C., Montgomery, L., Mahaffey, R., Downar, J., Clarke, H., Muscedere, J., Rittenbach, K., Featherstone, R., Sebastianski, M., Vandermeer, B., Lynam, D., Magnussen, R., Bagshaw, S. M., & Rewa, O. G. (2019). Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: A protocol for a systematic review and meta-analysis. Systematic Reviews, 8(1), 1-8. BioMed Central.

11.  Eucker, S. A., Knisely, M. R., & Simon, C. B. (2022). Nonopioid treatments for chronic pain—Integrating multimodal biopsychosocial approaches to pain management. JAMA Network Open, 5(6), e2216482–e2216482.

12.  Faouzi, A., Varga, B., & Majumdar, S. (2020). Biased opioid ligands. Molecules, 25(18), 4257. Multidisciplinary Digital Publishing Institute.

13.  Griffin, P. M. (2020). Engineering approaches for addressing opioid use disorder in the community. Annual Review of Biomedical Engineering, 22(1). Annual Reviews.

14.  Ito, A., Yang, S., Shinto, E., Shinto, A., Toyofuku, A., & Kurata, J. (2024). Interhemispheric and corticothalamic white-matter dysfunction underlies affective morbidity and impaired pain modulation in chronic pain. Anesthesia & Analgesia. Lippincott Williams & Wilkins.

15.  Jeddi, H., Busse, J. W., Sadeghirad, B., Levine, M., Zoratti, M. J., Wang, L., Noori, A., Couban, R., & Tarride, J. (2023). Cannabis for medical use versus opioids for chronic non-cancer pain: A systematic review and network meta-analysis of randomised clinical trials. BMJ Open, 14. McMaster University.

16.  Jiménez-Fernández, B., Calomarde-Gómez, C., Lopez-Lazcano, A., Lligoña, A., Gual, A., & López-Pelayo, H. (2022). Systematic review on the clinical management of chronic pain and comorbid opioid use disorder. Adicciones, 0(2), 1680–1680.

17.  Khan, M. I. H., Sawyer, B. J., Akins, N. S., & Le, H. V. (2022). A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse. European Journal of Medicinal Chemistry, 243, 114785–114785.

18.  Kiritoshi, T., Yakhnitsa, V., Singh, S., Wilson, T. D., Chaudhry, S., Neugebauer, B., Torres-Rodriguez, J. M., Lin, J. L., Carrasquillo, Y., & Neugebauer, V. (2024). Cells and circuits for amygdala neuroplasticity in the transition to chronic pain. Volume 43, Issue 9114669. Open access.

19.  Kummer, K. K., & Sheets, P. L. (2024). Targeting PFC dysfunction in pain. Journal of Pharmacology and Experimental Therapeutics. American Society for Pharmacology and Experimental Therapeutics, JPET-002046.

20.  Leis, J. A., & Morrison, C. I. (2021). An integrative review of arts-based strategies for addressing pain and substance use disorder during the opioid crisis. Health Promotion Practice, 22. SAGE Publications.

21.  Medina, S., Clarke, S., & Hughes, S. W. (2024). Virtual reality-based analgesia: Towards a novel framework for the biopsychosocial management of chronic pain. BJA: British Journal of Anaesthesia. Elsevier BV.

22.  Munneke, W., De Kooning, M., Nijs, J., Morin, C., Berquin, A., Meeus, M., Hartvigsen, J., & Demoulin, C. (2024). Enhancing healthcare professionals' biopsychosocial perspective to chronic pain: Assessing the impact of implementing an interdisciplinary training program. Pain. Lippincott Williams & Wilkins.

23.  Oliveira, D., Mendonça, L., Sampaio, R., Castro-Lopes, J. M., & Azevedo, L. F. (2019). The impact of anxiety and depression on the outcomes of chronic low back pain multidisciplinary pain management—A multicenter prospective cohort study in pain clinics with one-year follow-up. Pain Medicine, 20(4), 736-746. Oxford Academic.

24.  Ongaro, G. (2024). Outline for an externalist psychiatry (1): Or, how to fully realize the biopsychosocial model. Philosophy, Psychiatry, & Psychology, 31(3), 269–284. Johns Hopkins University Press.

25.  Quidé, Y., Jahanshad, N., Andoh, J., Antoniou, G., Apkarian, A. V., Ashar, Y. K., Badran, B. W., Baird, C. L., Baxter, L., Bell, T., Blanco‐Hinojo, L., Borckardt, J. J., Cheung, C. W., Ciampi de Andrade, D., Couto, B. A. C., Cox, S. R., Cruz‐Almeida, Y., Dannlowski, U., De Martino, E., de Tommaso, M., Deus, J., Domín, M., Egorova, N., Elliott, J. M., Fanton, S., Fauchon, C., Flor, H., Franz, C. E., Gatt, J. M., Gerdhem, P., Gilman, J. M., Gollub, R. L., Govind, V., Graven‐Nielsen, T., Håkansson, G., Hales, T. G., Haswell, C. C., Heukamp, N. J., Hu, L., Huang, L., Hussain, A., Jensen, K., Kircher, T., Kremen, W. S., Leehr, E. J., Lindquist, M. A., Loggia, M. L., Lotze, M., Martucci, K. T., Meeker, T. J., Meinert, S., Millard, S. K., Morey, R. A., Murillo, C., Nees, F., Nenadić, I., Park, H. R. P., Peng, X., Ploner, M., Pujol, J., Robayo, L. E., Salan, T., Seminowicz, D. A., Serian, A., Slater, R., Stein, F., Stevens, J. S., Strauß, S., Sun, D., Vachon‐Presseau, É., Valdés-Hernández, P. A., Vanneste, S., Vernon, M., Verriotis, M., Wager, T. D., Widerström-Noga, E., Woodbury, A., Zeidan, F., Bhatt, R. R., Ching, C. R. K., Haddad, E., Thomopoulos, S. I., Thompson, P. M., & Gustin, S. M. (2024). ENIGMA-Chronic Pain: A worldwide initiative to identify brain correlates of chronic pain. Pain. Lippincott Williams & Wilkins.

26.  Ribeiro, A., Loureiro, R., & Cabral-Marques, H. (2024). Enhancing cannabinoid bioavailability in pain management: The role of cyclodextrins. Molecules, 29(22), 53. Multidisciplinary Digital Publishing Institute.

27.  Rudolph, K. E., Díaz, I., Hejazi, N. S., van der Laan, M. J., Luo, S. X., Shulman, M., Campbell, A. N. C., Rotrosen, J., & Nunes, E. V. (2021). Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables. Addiction, 116(8), 2094-2103. John Wiley & Sons, Ltd.

28.  Scott, A. J., Bisby, M. A., Heriseanu, A. I., Salameh, Y., Karin, E., Fogliati, R., Dudeney, J., Gandy, M., McLellan, L. F., Wootton, B. M., McDonald, S., Correa, A. B., Titov, N., & Dear, B. F. (2023). Cognitive behavioral therapies for depression and anxiety in people with chronic disease: A systematic review and meta-analysis. Clinical Psychology Review, 30 September. University of Sydney and Macquarie University.

29.  Secondulfo, C., Mazzeo, F., Pastorino, G. M. G., Vicidomini, A., Meccariello, R., & Operto, F. F. (2024). Opioid and cannabinoid systems in pain: Emerging molecular mechanisms and use in clinical practice, health, and fitness. International Journal of Molecular Sciences, 25(17), 9407-9407. Multidisciplinary Digital Publishing Institute.

30.  Sheng, J., Liu, S., Wang, Y., Cui, R., & Zhang, X. (2017). The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plasticity, 2017, 9724371.

31.  Silva, M. J. (2024). Treating anxiety-based cognitive distortions pertaining to somatic perception for better chronic pain outcomes: A recommendation for better practice in the present day and the cyber age of medicine. Stomatology, 13(19), pp. Multidisciplinary Digital Publishing Institute.

32.  Thompson, J. M., Chang, Y. H., & Creed, M. C. (2024). Chronic pain-related hypoexcitability of accumbal-projecting mesolimbic dopamine neurons is associated with altered performance on reward learning tasks. The Journal of Pain.

33.  Zorina-Lichtenwalter, K., Bango, C. I., Ceko, M., Rader, L., Lindquist, M. A., Friedman, N. P., & Wager, T. D. (2024). Brain correlates of chronic pain onset, progression, and resolution. The Journal of Pain.

About the Author

Dr. Wesley Sassaman is a medical professional with nearly a decade of experience in addiction and mental health. Working on the front lines of the fentanyl epidemic in Scottsdale, Arizona , Dr. Sassaman is dedicated to empowering families affected by fentanyl addiction by providing them with the knowledge and resources to navigate the difficult road to recovery. With a deep understanding of the biopsychosocial model of addiction, Dr. Sassaman combines expert insights with compassionate guidance, offering hope to those struggling with the devastating effects of street-based fentanyl addiction. Each blog post invites readers into a transformative conversation, bridging the gap between despair and hope while illuminating a path toward healing and resilience.